-
Africa: Third New TB Drug in Over 50 Years Must Be Affordable
MSF, 15 August 2019
Médecins Sans Frontières (MSF) welcomed today's approval by the US Food and Drug Administration (FDA) of a combination regimen containing a new drug, pretomanid, for… Read more »
-
Nigeria: Drug Resistance Threatens Tuberculosis Management - Report
Vanguard, 13 August 2019
A new report by the Economist Intelligence Unit, EIU, has sounded the alarm about the threat of drug-resistant tuberculosis in Nigeria and other tuberculosis high burden countries… Read more »
Third New TB Drug in Over Half a Century 'Must Be Affordable'
This new drug could dramatically shorten treatment length to between six and nine months, greatly reduce the number of pills required, and help to increase extensively drug-resistant tuberculosis cure rates from the poor historical figure of 34%.
InFocus
-
Prisons authorities have expressed concern over the high prevalence of tuberculosis (TB) among inmates due to overwhelming numbers. The high figures are blamed on overcrowding, ... Read more »
-
In the scientific language of the University of Cape Town's announcement, the project will "focus on addressing the issue of variability in drug response across African ... Read more »
-
"TB remains the world's deadliest infectious killer. Each day, nearly 4,500 people lose their lives to TB and close to 30,000 people fall ill with this preventable and curable ... Read more »
